Matches in Wikidata for { <http://www.wikidata.org/entity/Q96143414> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q96143414 description "clinical trial" @default.
- Q96143414 description "ensayo clínico" @default.
- Q96143414 description "ensayu clínicu" @default.
- Q96143414 description "klinisch onderzoek" @default.
- Q96143414 description "клінічне випробування" @default.
- Q96143414 description "կլինիկական փորձարկում" @default.
- Q96143414 description "临床试验" @default.
- Q96143414 name "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 name "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 type Item @default.
- Q96143414 label "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 label "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 prefLabel "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 prefLabel "Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy" @default.
- Q96143414 P1050 Q96143414-D706F206-C4B5-4828-A8CC-99614FE790E5 @default.
- Q96143414 P1132 Q96143414-30BE0D51-957E-4C08-A084-7BC013B448A6 @default.
- Q96143414 P1476 Q96143414-62F09A57-321E-4C4D-9935-384021CD29C9 @default.
- Q96143414 P17 Q96143414-B520B4AB-72C6-4AF3-9CCC-992A2EF8FFE1 @default.
- Q96143414 P1813 Q96143414-3DA96A81-A96E-41FA-905C-5678141D1D94 @default.
- Q96143414 P2899 Q96143414-6AE688A6-666A-4133-9977-C2E2FF8BDB8A @default.
- Q96143414 P3098 Q96143414-45D3734A-4D5B-4A04-AE4D-1BB6C261B2D4 @default.
- Q96143414 P31 Q96143414-24D7F3F2-DBA9-4152-AAF0-9B8CEE77111E @default.
- Q96143414 P4135 Q96143414-A1C305F5-4B11-47A2-A519-B49B3A90E58B @default.
- Q96143414 P580 Q96143414-4F76005F-CA19-455E-AC8E-297F4041782D @default.
- Q96143414 P582 Q96143414-AE73D44A-986F-44F9-AE08-70EDCAB130A5 @default.
- Q96143414 P6099 Q96143414-53F297B8-6D1B-46F0-BDFE-AB8EDF06306F @default.
- Q96143414 P8005 Q96143414-E321B6DC-AD23-4EB9-BA17-10D762F98A07 @default.
- Q96143414 P8363 Q96143414-E9DA4D15-50B3-4E62-A63A-EC9B9DD04AA7 @default.
- Q96143414 P921 Q96143414-A834FB05-9806-4CD0-B7CB-D984220F698E @default.
- Q96143414 P921 Q96143414-DE1EC743-2B0D-48E6-9C2C-5980B1A27804 @default.
- Q96143414 P1050 Q816798 @default.
- Q96143414 P1132 "+145" @default.
- Q96143414 P1476 "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects With Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial)" @default.
- Q96143414 P17 Q30 @default.
- Q96143414 P1813 "ATTRibute-PN" @default.
- Q96143414 P2899 "+18" @default.
- Q96143414 P3098 "NCT04418024" @default.
- Q96143414 P31 Q30612 @default.
- Q96143414 P4135 "+90" @default.
- Q96143414 P580 "2020-06-24T00:00:00Z" @default.
- Q96143414 P582 "2024-03-31T00:00:00Z" @default.
- Q96143414 P6099 Q42824827 @default.
- Q96143414 P8005 Q76649614 @default.
- Q96143414 P8363 Q78089383 @default.
- Q96143414 P921 Q1502312 @default.
- Q96143414 P921 Q2844603 @default.